|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.54/-0.55
|
Enterprise Value
16.35M
|
Balance Sheet |
Book Value Per Share
1.25
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
1.55M
|
Operating Revenue Per Share
0.22
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/10/31 20:49 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consistsof silica-based microencapsulation technology platform, and several generic product candidates across multiple indications. |